‘Treatment holiday’ in prostate cancer with tailored dosingJuly 25, 2023Genitourinary CancerProstate Cancer
Cancer Data Trends 2023July 5, 2023Breast CancerGenitourinary CancerLung CancerProstate CancerColon and RectalMelanoma
Risk of falls seen with newer antiandrogens for prostate cancerJune 9, 2023Genitourinary CancerProstate Cancer
Prostate cancer subgroup may benefit from intensified therapyMarch 1, 2023Genitourinary CancerProstate CancerOncology
Talazoparib add-on improves outcomes in metastatic prostate cancerFebruary 22, 2023Genitourinary CancerProstate Cancer
Rucaparib benefit in BRCA+ prostate cancer confirmedFebruary 17, 2023Genitourinary CancerProstate Cancer
New cancer data spark outcry from patient advocatesJanuary 30, 2023OncologyGenitourinary CancerProstate Cancer
‘Low-value’ prostate cancer screening prevalent in primary careJanuary 9, 2023Genitourinary CancerOncologyProstate Cancer
Improving Bone Health in Patients With Advanced Prostate Cancer With the Use of Algorithm-Based Clinical Practice Tool at Salt Lake City VASeptember 14, 2022Prostate CancerOncology
Palliative Care Disparities in Small Cell Carcinoma of the Prostate: An Analysis of the National Cancer DatabaseSeptember 9, 2022Hospice & Palliative MedicineProstate CancerOncology
Utilization and Clinical Benefit of Immune Checkpoint Inhibitor in Veterans With Microsatellite Instability-High Prostate CancerSeptember 9, 2022Prostate CancerColon and RectalOncology
Impact of Race on Outcomes of High-Risk Patients With Prostate Cancer Treated With Moderately Hypofractionated Radiotherapy in an Equal Access SettingAugust 11, 2022Colon and RectalOncologyProstate Cancer
